Ezetimibe Shortage Update: What Patients Need to Know in 2026

If you take ezetimibe for high cholesterol and you've had trouble filling your prescription recently, you're not imagining it. While ezetimibe is not currently on the FDA's official drug shortage list, individual pharmacies across the country sometimes run into temporary gaps in stock. Here's what you need to know in 2026.

Is There an Official Ezetimibe Shortage in 2026?

No — as of 2026, the FDA has not designated ezetimibe as a drug in shortage. The FDA drug shortage database tracks medications for which demand exceeds supply at a national level, typically due to manufacturing problems, raw material issues, or single-source manufacturing. Ezetimibe does not currently meet these criteria.

Generic ezetimibe 10 mg tablets are manufactured by dozens of pharmaceutical companies, including Teva, Mylan, Aurobindo, Apotex, and others. This multi-manufacturer landscape makes a true national shortage unlikely.

Why Are Some Patients Still Having Trouble Finding It?

Even without an official shortage, patients sometimes experience "rolling shortages" — situations where supply is technically available nationally, but individual pharmacies or regional wholesalers are temporarily out. This can happen for several reasons:

Demand spikes: An aging population and updated cardiovascular guidelines recommending earlier cholesterol intervention have increased ezetimibe demand significantly in recent years.

Wholesaler delays: A pharmacy's primary drug wholesaler may be temporarily backordered on a specific generic manufacturer's version of ezetimibe, even if other manufacturers have stock.

Formulary preferences: Insurance plans and pharmacy benefit managers (PBMs) sometimes prefer specific generic manufacturers for pricing reasons. If that manufacturer faces a delay, covered patients may be redirected to different options.

Small pharmacy inventory: Independent and smaller pharmacies keep leaner inventories. If a batch sells out faster than expected, they may run out between restock orders.

Ezetimibe Shortage History: Has This Happened Before?

Ezetimibe has not been formally listed on the FDA drug shortage database historically. Unlike medications such as Adderall, semaglutide, or albuterol inhalers that have made headlines for widespread shortages in recent years, ezetimibe has a strong generic manufacturing base that has kept up with demand.

Occasional localized shortages have been reported anecdotally by patients on cholesterol forums, but these have typically resolved within days as pharmacies reorder from alternate suppliers.

What Should Patients Do Right Now?

If you're having trouble finding ezetimibe, here are the most important steps to take:

Don't stop your medication abruptly — call your doctor to let them know you're having trouble filling it.

Ask your pharmacy if they can order it from an alternate supplier or manufacturer.

Call 2-3 nearby chain pharmacies to check availability (CVS, Walgreens, Walmart tend to have the best stock).

Use medfinder to have pharmacies checked on your behalf — they'll text you results.

Consider switching to 90-day mail-order fills to avoid this problem in the future.

Should You Be Worried About Long-Term Supply?

The long-term supply outlook for ezetimibe is stable. As a generic drug manufactured by many companies, it does not face the same single-point-of-failure risks as brand-only medications or drugs with complex manufacturing processes. The current challenges patients face are distribution-level, not production-level.

If you're struggling to locate your medication, medfinder takes the guesswork out of finding a pharmacy that has it in stock today.

See also: How to find ezetimibe in stock near you (tools + tips).